"L’Institut de Cancérologie de l’Ouest (ICO) est un Centre de Lutte Contre le Cancer qui a pour mission le soin, la recherche et l’enseignement.Du diagnostic rapide à la chirurgie, la chimiothérapie, la radiothérapie, la prise en charge s'étend également aux soins de support. Spécialisés en cancérologie, les professionnels de l'ICO accompagnent les patients à toutes les étapes de leur parcours de soins, de manière personnalisée, innovante et multidisciplinaire. Consultations sans dépassement d..."

During the past decade, Institut de Cancerologie de l'Ouest conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Institut de Cancerologie de l'Ouest" are "Advanced or Inoperable Gastric Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Head and Neck Neoplasms" (1 trials), "Non Small Cell Lung Cancer Metastatic" (1 trials) and "Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Institut de Cancerologie de l'Ouest" in a lesser frequency.

Most popular intervention types in "Institut de Cancerologie de l'Ouest" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Carboplatin" (1 trials), "Cetuximab" (1 trials), "Cisplatin" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut de Cancerologie de l'Ouest" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Institut de Cancerologie de l'Ouest". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Institut de Cancerologie de l'Ouest, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Institut de Cancerologie de l'Ouest, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".